What would happen if there was a decades-old drug that was only effective for a very small number of patients, had potential bad side effects and was rapidly being eclipsed by more effective drugs, yet a vocal minority continued to push this drug as the cure-all, and wanted to require everyone to take it?
In all likelihood, no one would take this snake oil sales pitch seriously.
More Updates
EMV Not an End-All for Card Security
American Banker
Read
Op-Ed
Cloakroom Confidential: Durbin Pushes ‘Chip & Pin’ Scheme Despite Security Flaws
Daily Surge
Read
ABA Survey: 94 Percent of Consumers Say Retailers Should Improve Security Systems to Protect Financial Information
American Bankers Association
Read
Press Releases / Statements